99 related articles for article (PubMed ID: 34528761)
21. A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer.
Seigneurin A; Field JK; Gachet A; Duffy SW
Ann Oncol; 2014 Apr; 25(4):781-791. PubMed ID: 24297084
[TBL] [Abstract][Full Text] [Related]
22. Prognostic effect of implementation of the mass low-dose computed tomography lung cancer screening program: a hospital-based cohort study.
Wu FZ; Huang YL; Wu YJ; Tang EK; Wu MT; Chen CS; Lin YP
Eur J Cancer Prev; 2020 Sep; 29(5):445-451. PubMed ID: 32740170
[TBL] [Abstract][Full Text] [Related]
23. Lung cancer screening adherence among people living with and without HIV: An analysis of an integrated health system in Florida, United States (2012-2021).
Islam JY; Yang S; Schabath M; Vadaparampil ST; Lou X; Wu Y; Bian J; Guo Y
Prev Med Rep; 2023 Oct; 35():102334. PubMed ID: 37546581
[TBL] [Abstract][Full Text] [Related]
24. Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis.
Hu L; Lin JY; Sigel K; Kale M
Ann Epidemiol; 2021 Oct; 62():36-42. PubMed ID: 34157399
[TBL] [Abstract][Full Text] [Related]
25. The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-up.
Bhamani A; Horst C; Bojang F; Quaife SL; Dickson JL; Tisi S; Hall H; Verghese P; Creamer A; Prendecki R; McCabe J; Gyertson K; Bowyer V; El-Emir E; Cotton A; Mehta S; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Janes SM
Lung Cancer; 2023 Feb; 176():75-81. PubMed ID: 36621036
[TBL] [Abstract][Full Text] [Related]
26. Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population.
Yi S; Rathod RA; Natchimuthu VS; Bhalla S; Lee JL; Browning T; Adesina JO; Do M; Balis D; de Wiliams JG; Kitchell E; Santini NO; Johnson DH; Hamann HA; Lee SJC; Hughes AE; Gerber DE
J Natl Compr Canc Netw; 2024 Apr; ():1-7. PubMed ID: 38670152
[TBL] [Abstract][Full Text] [Related]
27. Challenges in Lung Cancer Screening in Latin America.
Raez LE; Nogueira A; Santos ES; Dos Santos RS; Franceschini J; Ron DA; Block M; Yamaguchi N; Rolfo C
J Glob Oncol; 2018 Sep; 4():1-10. PubMed ID: 30241252
[TBL] [Abstract][Full Text] [Related]
28. Screening for lung cancer using thin-slice low-dose computed tomography in southwestern China: a population-based real-world study.
Wu J; Li R; Zhang H; Zheng Q; Tao W; Yang M; Zhu Y; Ji G; Li W
Thorac Cancer; 2024 May; ():. PubMed ID: 38798230
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer screening with low-dose CT: a world-wide view.
Pinsky PF
Transl Lung Cancer Res; 2018 Jun; 7(3):234-242. PubMed ID: 30050762
[TBL] [Abstract][Full Text] [Related]
30. Role of sex in lung cancer risk prediction based on single low-dose chest computed tomography.
Simon J; Mikhael P; Tahir I; Graur A; Ringer S; Fata A; Jeffrey YC; Shepard JA; Jacobson F; Barzilay R; Sequist LV; Pace LE; Fintelmann FJ
Sci Rep; 2023 Oct; 13(1):18611. PubMed ID: 37903855
[TBL] [Abstract][Full Text] [Related]
31. Swiss Pilot Low-Dose CT Lung Cancer Screening Study: First Baseline Screening Results.
Jungblut L; Etienne H; Zellweger C; Matter A; Patella M; Frauenfelder T; Opitz I
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762713
[TBL] [Abstract][Full Text] [Related]
32. Program-Based Lung Cancer Care: A Prospective Observational Tumor Registry Linkage Study.
Liao W; Ray M; Fehnel C; Goss J; Shepherd CJ; Patel A; Qureshi T; Caro F; Roma J; Derrick A; Matthews AT; Faris NR; Smeltzer M; Osarogiagbon RU
JTO Clin Res Rep; 2024 Feb; 5(2):100629. PubMed ID: 38322712
[TBL] [Abstract][Full Text] [Related]
33. Initial low-dose computed tomography screening results and summary of participant characteristics: based on the latest Chinese guideline.
Zhang Z; Gao Y; Liu S; Ding B; Zhang X; Wu IXY
Front Oncol; 2023; 13():1085434. PubMed ID: 37293585
[TBL] [Abstract][Full Text] [Related]
34. Procedural complications associated with invasive diagnostic procedures after lung cancer screening with low-dose computed tomography.
Yang S; Shih YT; Huo J; Mehta HJ; Wu Y; Salloum RG; Alvarado M; Zhang D; Braithwaite D; Guo Y; Bian J
Lung Cancer; 2022 Mar; 165():141-144. PubMed ID: 35124410
[TBL] [Abstract][Full Text] [Related]
35. Historical Perspective on Lung Cancer Screening.
Salfity HVN; Tong BC; Kocher MR; Tailor TD
Thorac Surg Clin; 2023 Nov; 33(4):309-321. PubMed ID: 37806734
[TBL] [Abstract][Full Text] [Related]
36. The person behind the nodule: a narrative review of the psychological impact of lung cancer screening.
Quaife SL; Janes SM; Brain KE
Transl Lung Cancer Res; 2021 May; 10(5):2427-2440. PubMed ID: 34164290
[TBL] [Abstract][Full Text] [Related]
37. Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial.
Davies MPA; Vulkan D; Gabe R; Duffy SW; Field JK
Lancet Reg Health Eur; 2024 Jul; 42():100936. PubMed ID: 38813535
[TBL] [Abstract][Full Text] [Related]
38. The Association of Organizational Readiness With Lung Cancer Screening Utilization.
Lewis JA; Samuels LR; Weems J; Park D; Winter R; Lindsell CJ; Callaway-Lane C; Audet C; Slatore CG; Wiener RS; Dittus RS; Kripalani S; Yankelevitz DF; Henschke CI; Moghanaki D; Matheny ME; Vogus TJ; Roumie CL; Spalluto LB
Am J Prev Med; 2023 Nov; 65(5):844-853. PubMed ID: 37224985
[TBL] [Abstract][Full Text] [Related]
39. Lung Cancer Screening: All That Glitters Is Not Gold.
Doppalapudi S; Venkatram S; Baqui AA; Diaz-Fuentes G
Cureus; 2024 Apr; 16(4):e57783. PubMed ID: 38721157
[TBL] [Abstract][Full Text] [Related]
40. The use of biomarkers in the diagnosis of lung cancer.
Mlika M; Mezni F
Tunis Med; 2023 Apr; 101(4):398-403. PubMed ID: 38372537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
